Dimethyl fumarate may still have a role in progressive multiple sclerosis

Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study

(2014) Katrin Strassburger-Krogias et al.   Therapeutic Advances in Neurological Disorders

CD8+T cells in multiple sclerosis

(2013) Aleksandar Denic et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis

(2013) Domenico Plantone et al.   JOURNAL OF NEUROIMMUNOLOGY

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

(2012) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

(2012) Ralf Gold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Circulating CD8+CD56−perforin+ T cells are increased in multiple sclerosis patients

(2011) Giovanni Frisullo et al.   JOURNAL OF NEUROIMMUNOLOGY

CD8+ T Cells Cause Disability and Axon Loss in a Mouse Model of Multiple Sclerosis

(2010) Chandra Deb et al.   PLoS One

Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis

(2009) Kimmy G. Su et al.   Current Neurology and Neuroscience Reports